UNICYCIVE THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.8% | -60.8% | -53.4% |
| FY2022 | 3,875.1% | 3,875.1% | -640.8% |
| FY2023 | 801.9% | 801.9% | -215.2% |
| FY2024 | -494.3% | -494.3% | -116.0% |
| FY2025 | -87.9% | -87.9% | -54.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.8% | -60.8% | -53.4% |
| FY2022 | 3,875.1% | 3,875.1% | -640.8% |
| FY2023 | 801.9% | 801.9% | -215.2% |
| FY2024 | -494.3% | -494.3% | -116.0% |
| FY2025 | -87.9% | -87.9% | -54.0% |